Adare Pharma Solutions, in collaboration with Laxxon Medical, offers clinical scale cGMP 3D printing capabilities from Adare facilities in the US and Europe. This innovative technology empowers a wide range of enhanced dose flexibility capabilities.
3D printing allows for the formulation of complex pharmaceuticals with optimized properties, including freely customizable release profiles of one or more APIs, improved bioavailability, shape modifications for ease of swallowing, and tailored pharmacokinetics.
The platform enables production of multi-compartment tablets ranging from as small as 200 microns up to centimeters in diameter, as well as a direct upscale from lab- to mass-production without changing the production process.
